| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $114.2M | +39.4% |
| SG&A Expense | $49.9M | +2.5% |
| Operating Income | -$164.2M | -25.7% |
| Pre-tax Income | -$134.9M | -12.9% |
| Income Tax | $1.0M | +128.4% |
| Net Income | -$136.0M | -17.3% |
| EPS (Basic) | -$1.63 | -17.3% |
| EPS (Diluted) | -$1.63 | -17.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $143.8M | -23.7% |
| Current Assets | $590.5M | -10.7% |
| Total Assets | $595.0M | -10.8% |
| Current Liabilities | $32.4M | +75.2% |
| Total Liabilities | $39.8M | +52.2% |
| Stockholders' Equity | $555.2M | -13.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$85.4M | +29.4% |
| Capital Expenditures | $1.9M | +0.0% |
| Investing Cash Flow | $40.3M | +108.8% |
| Financing Cash Flow | $257K | -30.5% |
| Free Cash Flow | -$87.3M | +29.0% |